These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 9481469)

  • 1. Respiratory syncytial virus immune globulin intravenous (human) receives marketing approval in Canada.
    Langley JM
    Can Fam Physician; 1998 Jan; 44():113. PubMed ID: 9481469
    [No Abstract]   [Full Text] [Related]  

  • 2. Prevention of respiratory syncytial virus infection in high risk infants: consensus opinion on the role of immunoprophylaxis with respiratory syncytial virus hyperimmune globulin.
    Meissner HC; Welliver RC; Chartrand SA; Fulton DR; Rodriguez WJ; Groothuis JR
    Pediatr Infect Dis J; 1996 Dec; 15(12):1059-68. PubMed ID: 8970212
    [No Abstract]   [Full Text] [Related]  

  • 3. Novel mutations in the respiratory syncytial virus G gene identified in viral isolates from a girl with severe combined immune deficiency treated with intravenous immune globulin.
    Lazar I; Canaan A; Weibel C; Kahn JS
    J Clin Virol; 2006 Nov; 37(3):168-73. PubMed ID: 16949862
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quantitative effects of palivizumab and donor-derived T cells on chronic respiratory syncytial virus infection, lung disease, and fusion glycoprotein amino acid sequences in a patient before and after bone marrow transplantation.
    El Saleeby CM; Suzich J; Conley ME; DeVincenzo JP
    Clin Infect Dis; 2004 Jul; 39(2):e17-20. PubMed ID: 15307047
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Revised indications for the use of palivizumab and respiratory syncytial virus immune globulin intravenous for the prevention of respiratory syncytial virus infections.
    American Academy of Pediatrics Committee on Infectious Diseases and Committee on Fetus and Newborn
    Pediatrics; 2003 Dec; 112(6 Pt 1):1442-6. PubMed ID: 14654627
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Respiratory syncytial virus immune globulin and conflict of interest.
    Groothuis JR
    N Engl J Med; 1998 Nov; 339(22):1644. PubMed ID: 9867534
    [No Abstract]   [Full Text] [Related]  

  • 7. Respiratory syncytial virus PREVENT Study questions.
    Raju TN
    Pediatrics; 1997 Dec; 100(6):1044; author reply 1045. PubMed ID: 9411386
    [No Abstract]   [Full Text] [Related]  

  • 8. Respiratory syncytial virus-immunoglobulin intravenous (RSV-IGIV) for respiratory syncytial viral infections: Part II.
    Sandritter TL; Kraus DM
    J Pediatr Health Care; 1998; 12(2):85-9; quiz 90-2. PubMed ID: 9592442
    [No Abstract]   [Full Text] [Related]  

  • 9. Respiratory syncytial virus PREVENT Study questions.
    Moler FW
    Pediatrics; 1997 Dec; 100(6):1043-4; author reply 1045. PubMed ID: 9411385
    [No Abstract]   [Full Text] [Related]  

  • 10. Prophylaxis against respiratory syncytial virus in high-risk infants: administration of immune globulin and epidemiological surveillance of infection.
    Handal G; Logvinoff MM; Zegarra N; Allen L; Jesurun A; Levin G; Thida A
    Tex Med; 2000 May; 96(5):58-61. PubMed ID: 10843015
    [TBL] [Abstract][Full Text] [Related]  

  • 11. New guidelines proposed for use of RSV immune globulin.
    Am J Health Syst Pharm; 1997 May; 54(9):1025. PubMed ID: 9143648
    [No Abstract]   [Full Text] [Related]  

  • 12. Respiratory syncytial virus immune globulin treatment of lower respiratory tract infection in pediatric patients undergoing bone marrow transplantation - a compassionate use experience.
    DeVincenzo JP; Hirsch RL; Fuentes RJ; Top FH
    Bone Marrow Transplant; 2000 Jan; 25(2):161-5. PubMed ID: 10673674
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of severe disease caused by respiratory syncytial virus in children living in developed countries.
    Simoes EA; Carbonell-Estrany X
    Pediatr Infect Dis J; 2003 Feb; 22(2 Suppl):S13-8; discussion S18-20. PubMed ID: 12671448
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunoprophylaxis of respiratory syncytial virus infection.
    Simoes EA
    Indian Pediatr; 2000 Mar; 37(3):243-7. PubMed ID: 10750065
    [No Abstract]   [Full Text] [Related]  

  • 15. Prophylaxis for severe respiratory syncytial virus disease.
    Kupecz D
    Nurse Pract; 1996 Sep; 21(9):116-8. PubMed ID: 8884798
    [No Abstract]   [Full Text] [Related]  

  • 16. Cost estimates of prophylaxis.
    Moler F
    Arch Pediatr Adolesc Med; 2001 Feb; 155(2):199-200. PubMed ID: 11177100
    [No Abstract]   [Full Text] [Related]  

  • 17. Pericarditis mediated by respiratory syncytial virus in a hematopoietic stem cell transplant patient.
    Rubach MP; Pavlisko EN; Perfect JR
    Transpl Infect Dis; 2013 Aug; 15(4):E152-6. PubMed ID: 23725410
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Respiratory syncytial virus infection in adults.
    Murata Y
    Curr Opin Pulm Med; 2008 May; 14(3):235-40. PubMed ID: 18427247
    [TBL] [Abstract][Full Text] [Related]  

  • 19. New vaccines against mucosal pathogens: rotavirus and respiratory syncytial virus.
    Coffin SE; Offit PA
    Adv Pediatr Infect Dis; 1997; 13():333-48. PubMed ID: 9544318
    [No Abstract]   [Full Text] [Related]  

  • 20. Prevention of bronchiolitis.
    Pringle CR
    Paediatr Respir Rev; 2000 Sep; 1(3):228-34. PubMed ID: 12531084
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.